XPO1 and neoplasm: Though there is not a clear understanding of what drives XPO1 overexpression as a primary or secondary event in tumor development, it has been shown that knockdown of the tumor suppressor TP53 results in increased XPO1 expression, while knockdown of the proto-oncogene C-MYC results in decreased XPO1 expression [70].